Scientific and Technological Advances as Current Challenges to the Biological Weapons Non-Proliferation Regime

The recent advances in biological sciences and biotechnology have resulted in new knowledge and capabilities that  challenge existing understandings of biological threats and biological weapons (BW). The purpose of the article is to  evaluate scientific and engineering decisions that pose potential challenges to the biological weapons non-proliferation  regime and can reduce barriers to their development, production and use. Materials and methods. The scientific articles  available through the PubMed, Google Scholar and Russian Electronic Library databases were used in the research.  The method of analysis is the description. The results of the research. The success of biotechnology provides impetus for  experimentation with biological weapons, particularly by non-state actors such as terrorist organizations and extremist  groups. Transformative changes are occurring in areas not directly related to microbiology. However, the potential for  their malicious use is no less of a concern than the development, production and stockpiling of biological weapons.  The transformation of the concept of «biological threat» is traced. It becomes more complex and includes elements  from other fields outside of biotechnology and the traditional understanding of biological weapons. In addition to  biotechnology and synthetic biology, such technologies that are directly related to the BTWC issue, may include:  additive manufacturing based on 3D printing technologies; big data analysis and artificial intelligence technologies;  nanotechnology and materials science, as well as biological research automation and robotics. Conclusion. Many dual-use technologies have received close attention from the scientific community and international experts, but this does  not always contribute to an accurate and balanced understanding of their potential in the context of BTWC issues. The  convergence of new and emerging disciplines is creating new areas of scientific knowledge that address the problem of  non-proliferation of biological weapons, which requires the expert community to make a balanced assessment from  the point of view of both dual use and the risk of excessive prohibition and negative impact on further scientific and  technological progress.

1. Berger KM, Casagrande RJ. Twentieth-century nonproliferation meets twenty-first-century biotechnology. The Nonproliferation Review. 2020;27(4-6):541–55. https://doi.org/10.1080/10736700.2020.1819690

2. Mackby J. Experts Debate Biological Weapons Challenges. Arms Control Today; 2018. www.armscontrol.org/act/2018-09/news/experts-debate-biological-weapons-challenges

3. Shearer MP, Montague M, Kobokovich A, Martin E, Connell N, Watson M, Gronvall GK. Global Forum on Scientific Advances Important to the Biological & Toxin Weapons Convention. Johns Hopkins Center for Health Security; 2019. www.centerforhealthsecurity.org/our-work/events/2019-global-forum/200925-2019 GlobalForumMtgRpt.pdf

4. Trump BD, Cummings CL, Kuzma J, Linkov I, Eds. Synthetic biology 2020: frontiers in risk analysis and governance. Cham: Springer; 2020.

5. National Academies of Sciences, Engineering, and Medicine. Biodefense in the Age of Synthetic Biology. Washington, DC: The National Academies Press; 2018. https://doi.org/10.17226/24890

6. El Karoui M, Hoyos-Flight M, Fletcher L. Future Trends in Synthetic Biology – A report. Front Bioeng Biotechnol. 2019;7:175. https://doi.org/10.3389/fbioe.2019.00175

7. Cross G, Klotz L. Twenty-first century perspectives on the Biological Weapon Convention: Continued relevance or toothless paper tiger. Bulletin of the Atomic Scientists. 2020;76(4):185–91. https://doi.org/10.1080/00963402.2020.1778365

8. Ostrov N, Beal J, Ellis T, Gordon DB, Karas BJ, Lee HH, et al. Technological challenges and milestones for writing genomes. Science. 2019;366;(6463):310–2. https://doi.org/10.1126/science.aay0339

9. Matai I, Kaur G, Seyedsalehi A, McClinton A, Laurencin CT. Progress in 3D bioprinting technology for tissue/organ regenerative engineering. Biomaterials. 2020;226:119536. https://doi.org/10.1016/j.biomaterials.2019.119536.

10. Cello J, Paul AV, Wimmer E. Chemical Synthesis of Poliovirus CDNA: Generation of Infectious Virus in the Absence of Natural Template. Science. 2002;297(5583):1016–18. https://doi.org/10.1126/science.107.2266

11. Noyce RS, Lederman S, Evans DH. Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments. PloS One. 2018;13(1):e0188453. https://doi.org/10.1371/journal.pone.0188453

12. Chen D, Kenney D, Chin C, Tavares AH, Khan N, Conway HL, et al. Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1 Omicron. bioRxiv. 2022.10.13.512134. https://doi.org/10/1101/2022.10.13.512134

13. Gan W, Lin A. CRISP/Cas9 in plant biotechnology: application and challenges. BioTechnologia. 2022;103(1):81–93. https://doi.org/10/5114/bta.2022.113919

14. El-Moandi K, Morales-Floriano ML, Garcia-Ruiz H. Principles, applications and biosafety of plant genome editing using CRISP-Cas9. Front Plant Sci. 2020;11:56. https://doi.org/10.3389/fpls.2020.00056

15. Ledford H, Callaway E. Gene Drive Mosquitoes Engineered to Fight Malaria. Nature. 2015. https://doi.org/10.1038/nature.2015.18858

16. Nixdorff K. Developments in systems biology: implications for health and biochemical security. The Nonproliferation Review, 2021;27:1–15. https://doi.org/10.1080/10736700.2020.1865632

17. Huigang L, Menghui L, Xiaoli Z, Cui H, Yuan Z. Development of and prospects for the biological weapons convention. Journal of Biosafety and Biosecurity. 2022;4:50–3. https://doi.org/10.1016/j.jobb.2021.11.003

18. Mooney SJ, Westreich DJ, El-Sayed AM. Commentary: epidemiology in the era of big data. Epidemiology. 2015;26(3):390–4. https://doi.org/10.1097/EDE.0000000000000274

19. Nixdorff K, Borisova T, Komisarenko S, Dando M. Dual-Use Nano-neurotechnology: An Assessment of the Implications of Trends in Science and Technology. Politics Life Sci. 2018;37(2):180–202. https://doi.org/10.1017/pls.2018.15

20. Musunuri S, Sandbrink JB, Monrad JT, Palmer MJ, Koblentz GD. Rapid proliferation of pandemic research: implications for dual-use risks. mBio. 2021;12(5):e0186421. https://doi.org/10.1128/mBio.01864-21

21. Frank GM, Adalja A, Barbour A, Casadevall A, Dormitzer PR, Duchin J, et al. Infectious Diseases Society of America and gain-of-function experiments with pathogens having pandemic potential. J Infect Dis. 2016;213(9):1359–61. https://doi.org/10.1093/infdis/jiv474

22. Schloss PD. Preprinting microbiology. mBio. 2017;8(3):e00438-17. https://doi.org/10.1128/mBio.00438-17

23. Khoury M, Iademarco M, Riley W. Precision public health for the era of precision medicine. American Journal of Preventive Medicine. 2016;50(3):398–401. https://doi.org/10.1016/j.amepre.2015.08.031

24. Dananjayan S, Raj GM. Artifiial intelligence during a pandemic: the COVID-19 example. Int J Health Plann Manage. 2020;35(5):1260-1262. https://doi.org/10.1002/hpm.2987

25. Warmbrod K, Revill J, Connell N. Advances in Science and Technology in the Life Sciences: Implications for Biosecurity and Arms Control. Geneva, Switzerland: UNIDIR; 2020. https://doi.org/10.37559/SecTec/20/SandT

26. Xu Y, Verma D, Sheridan RP, Liaw A, Ma J, Marshall NM, et al. Deep dive into machine learning models for protein engineering. J Chem Inf Model. 2020;60(6):2773–90. https://doi.org/10.1021/acs.jcim.0c00073

27. Bajema N, DiEullis D, Lutes C, Lim Y-B. The Digitization of Biology: Understanding the New Risks and Implications for Governance.Emergence & Convergence. Research paper no. 3. National Defense University; 2018. https://wmdcenter.ndu.edu/Publications/Publication-View/Article/1569559/the-digitization-of-biologyunderstanding-the-new-risks-and-implications-for-go/

28. Berger K, Schneck P. National and Transnational Security Implications of Asymmetric Access to and Use of Biological Data. Front Bioeng Biotechnol. 2019;7:21. https://doi.org/10.3389/fbioe.2019.00021

29. Urbina F, Lentzos F, Invernizzi C, Ekins S. Dual Use of Artificial Intelligence-powered Drug Discovery. Nat Mach Intell. 2022;4(3):189–91. https://doi.org/10.138/s42256-022-00465-9